Related Experiment Video
Updated: Jan 8, 2026
Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
Genetic Alterations in NSCLC: Prognostic Implications and Impact on Therapeutic Resistance
Bhardwaj Tina Neelesh1, Kanchan Bhardwaj1, Phani Mn2
1Manav Rachna International Institute of Research and Studies, Faridabad, Haryana.
Abstract:
Worldwide, the incidence of lung cancer is projected to continue its upward trend, with an estimated 2.5 million new cases annually. Non-small cell lung cancer (NSCLC) is the most prevalent form of lung cancer, accounting for ~85% of all cases. One of the challenges associated with NSCLC management is incomplete understanding of the underlying molecular mechanisms. Tumors often harbor multiple genetic changes that interact in complex ways, influencing tumor behavior, including the growth rate, metastatic potential as well as response and resistance to therapies. Identification of genetic alterations is desirable to anticipate resistance mechanisms and guide the development of combination therapies to overcome them. It also allows better stratification of patients in clinical trials, ensuring that the therapies are tested in the most appropriate populations, improving the chances of identifying effective treatments and tailor treatment plans based on the specific genetic profile of a patient's tumor. This review summarizes the established genetic and epigenetic alterations associated with NSCLC and discusses the need for understanding the molecular pathogenesis.
Insights
Non-small cell lung cancer (NSCLC) is a common cancer with complex genetic changes. Understanding these molecular alterations is key to developing effective treatments and improving patient outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Lung cancer incidence is rising globally, with Non-small cell lung cancer (NSCLC) comprising ~85% of cases.
- Current NSCLC management faces challenges due to an incomplete understanding of its molecular mechanisms.
- Tumors exhibit complex genetic interactions influencing growth, metastasis, and therapeutic response.
Purpose of the Study:
- To review established genetic and epigenetic alterations in NSCLC.
- To highlight the importance of understanding molecular pathogenesis for improved patient care.
- To discuss the need for identifying genetic alterations to guide therapy development.
Main Methods:
- Literature review of established genetic and epigenetic alterations in NSCLC.
- Analysis of the impact of genetic changes on tumor behavior and treatment response.
- Discussion of the role of molecular profiling in patient stratification and treatment planning.
Main Results:
- NSCLC tumors harbor multiple interacting genetic changes.
- Genetic alterations influence tumor growth, metastatic potential, and drug resistance.
- Identification of specific alterations can predict treatment response and resistance.
Conclusions:
- A comprehensive understanding of NSCLC molecular pathogenesis is crucial.
- Identifying genetic alterations aids in anticipating resistance and developing combination therapies.
- Molecular profiling enables personalized treatment strategies and better clinical trial design.
More Related Videos
08:52Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
Published on: November 22, 2021
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
Related Concept Videos
02:56Treatment Resistant Cancers
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:53Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:33Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...